Group One Trading, L.P. Madrigal Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

$3.01 Billion
Q2 2024

A detailed history of Group One Trading, L.P. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 76,399 shares of MDGL stock, worth $25.8 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

76,399

Previous 43,171 76.97%

Holding current value

$25.8 Million

Previous $11.5 Million 85.66%

% of portfolio

0.71%

Previous 0.43%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$193.33 - $291.99 $6.42 Million - $9.7 Million	33,228 Added 76.97%	76,399 $21.4 Million
Q1 2024 May 10, 2024	SELL	$171.37 - $283.23 $25.5 Million - $42.1 Million	-148,760 Reduced 77.51%	43,171 $11.5 Million
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $14 Million - $27.6 Million	116,243 Added 153.58%	191,931 $44.4 Million
Q3 2023 Nov 09, 2023	BUY	$146.04 - $225.78 $10.7 Million - $16.5 Million	73,004 Added 2719.97%	75,688 $11.1 Million
Q2 2023 Aug 09, 2023	BUY	$203.88 - $312.0 $547,213 - $837,408	2,684 New	2,684 $620,000
Q3 2022 Nov 09, 2022	BUY	$60.57 - $79.51 $543,615 - $713,602	8,975 Added 118.73%	16,534 $1.08 Million
Q2 2022 Aug 11, 2022	BUY	$58.04 - $100.2 $438,724 - $757,411	7,559 New	7,559 $541,000
Q4 2021 Feb 11, 2022	SELL	$72.34 - $95.09 $89,195 - $117,245	-1,233 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$78.35 - $105.02 $7,834 - $10,502	-100 Reduced 7.5%	1,233 $98,000
Q2 2021 Aug 10, 2021	BUY	$97.2 - $137.59 $38,880 - $55,036	400 Added 42.87%	1,333 $130,000
Q1 2021 May 12, 2021	SELL	$108.54 - $125.2 $253,115 - $291,966	-2,332 Reduced 71.42%	933 $109,000
Q4 2020 Feb 10, 2021	SELL	$110.06 - $133.7 $40,942 - $49,736	-372 Reduced 10.23%	3,265 $363,000
Q3 2020 Nov 12, 2020	BUY	$99.78 - $124.21 $349,230 - $434,735	3,500 Added 2554.74%	3,637 $432,000
Q2 2020 Aug 13, 2020	BUY	$60.13 - $125.71 $8,237 - $17,222	137 New	137 $16,000
Q4 2019 Feb 10, 2020	SELL	$84.28 - $118.5 $140,410 - $197,421	-1,666 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$84.4 - $106.53 $75,960 - $95,877	900 Added 117.49%	1,666 $144,000
Q2 2019 Aug 09, 2019	BUY	$91.13 - $142.5 $69,167 - $108,157	759 Added 10842.86%	766 $80,000
Q1 2019 May 13, 2019	BUY	$103.48 - $143.84 $724 - $1,006	7 New	7 $1,000

Others Institutions Holding MDGL

# of Institutions

294

Shares Held

21.8M

Call Options Held

757K

Put Options Held

370K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.78B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Madrigal Pharmaceuticals, Inc. Transaction History